1. Home
  2. MLYS vs SMP Comparison

MLYS vs SMP Comparison

Compare MLYS & SMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • SMP
  • Stock Information
  • Founded
  • MLYS 2019
  • SMP 1919
  • Country
  • MLYS United States
  • SMP United States
  • Employees
  • MLYS N/A
  • SMP N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • SMP Auto Parts:O.E.M.
  • Sector
  • MLYS Health Care
  • SMP Consumer Discretionary
  • Exchange
  • MLYS Nasdaq
  • SMP Nasdaq
  • Market Cap
  • MLYS 590.3M
  • SMP 708.3M
  • IPO Year
  • MLYS 2023
  • SMP N/A
  • Fundamental
  • Price
  • MLYS $13.88
  • SMP $31.53
  • Analyst Decision
  • MLYS Strong Buy
  • SMP Strong Buy
  • Analyst Count
  • MLYS 2
  • SMP 1
  • Target Price
  • MLYS $30.00
  • SMP $42.00
  • AVG Volume (30 Days)
  • MLYS 122.0K
  • SMP 240.8K
  • Earning Date
  • MLYS 11-05-2024
  • SMP 10-25-2024
  • Dividend Yield
  • MLYS N/A
  • SMP 3.68%
  • EPS Growth
  • MLYS N/A
  • SMP 2.49
  • EPS
  • MLYS N/A
  • SMP 1.76
  • Revenue
  • MLYS N/A
  • SMP $1,398,401,000.00
  • Revenue This Year
  • MLYS N/A
  • SMP $4.40
  • Revenue Next Year
  • MLYS N/A
  • SMP $2.33
  • P/E Ratio
  • MLYS N/A
  • SMP $11.65
  • Revenue Growth
  • MLYS N/A
  • SMP 2.02
  • 52 Week Low
  • MLYS $5.85
  • SMP $26.09
  • 52 Week High
  • MLYS $16.91
  • SMP $41.71
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 70.82
  • SMP 42.77
  • Support Level
  • MLYS $11.73
  • SMP $32.42
  • Resistance Level
  • MLYS $12.27
  • SMP $34.48
  • Average True Range (ATR)
  • MLYS 0.61
  • SMP 0.95
  • MACD
  • MLYS 0.19
  • SMP -0.27
  • Stochastic Oscillator
  • MLYS 98.50
  • SMP 7.10

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.

About SMP Standard Motor Products Inc.

Standard Motor Products Inc is a manufacturer and distributor of premium automotive parts used in the maintenance, service, and repair of vehicles in the automotive aftermarket industry. It operates into three business segments namely Engineered Solutions, Vehicle Control, and Temperature Control. The company focuses on the original equipment and original equipment services markets, with a product lineup of replacement parts for engine management ignition, emission, and fuel systems, as well as temperature-control products. The company operates majorly in the United States, with additional sales in Canada, Europe, Asia, Mexico, and other Latin American countries.

Share on Social Networks: